Literature DB >> 21646448

Relative efficacy of uptake and presentation of Mycobacterium bovis BCG antigens by type I mouse lung epithelial cells and peritoneal macrophages.

Mandavi Kumari1, Rajiv K Saxena.   

Abstract

Flow cytometric studies indicated that both peritoneal macrophages (PMs) and primary lung epithelial (PLE) cells isolated from mouse lungs could take up fluorescence-tagged Mycobacterium bovis BCG. BCG uptake in both cases was significantly inhibited by cytochalasin D, indicating active internalization of BCG by these cells. Confocal microscopy data further confirmed that BCG was internalized by PLE cells. BCG sonicate antigen (sBCG) had marked toxicity toward PMs but was relatively nontoxic to PLE cells. Accordingly, BCG sonicate antigen induced a significantly higher apoptotic and necrotic response in PMs compared to that in PLE cells. Both PMs and PLE cells exposed to BCG antigens and fixed thereafter could efficiently present antigens to purified BCG-sensitized T helper cells, as assessed by the release of interleukin-2 (IL-2) and gamma interferon (IFN-γ). If, however, PLE cells were fixed before exposure to BCG, antigen presentation was abrogated, indicating that the PLE cells may in some way process the BCG antigen. A comparison of efficacies of BCG-pulsed PLE cells and PMs to present antigen at various antigen-presenting cell (APC)/T cell ratios indicated that PMs had only marginally greater APC function than that of PLE cells. Staining with specific monoclonal antibodies indicated that the cultured PLE cells used for antigen presentation essentially comprised type I epithelial cells. Our results suggest that type I lung epithelial cells may present BCG antigens to sensitized T helper cells and that their performance as APCs is comparable with that of PMs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21646448      PMCID: PMC3147596          DOI: 10.1128/IAI.05406-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Surfactant proteins a and d and pulmonary host defense.

Authors:  E Crouch; J R Wright
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

2.  Nitric oxide production by peritoneal macrophages of Mycobacterium bovis BCG-infected or non-infected mice: regulatory role of T lymphocytes and cytokines.

Authors:  S Saito; M Nakano
Journal:  J Leukoc Biol       Date:  1996-06       Impact factor: 4.962

Review 3.  Antigen-presenting function of the macrophage.

Authors:  E R Unanue
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

4.  Murine model of BCG lung infection: dynamics of lymphocyte subpopulations in lung interstitium and tracheal lymph nodes.

Authors:  Rajiv K Saxena; David Weissman; Janet Simpson; Daniel M Lewis
Journal:  J Biosci       Date:  2002-03       Impact factor: 1.826

5.  Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines.

Authors:  Katsumasa Sato; Haruaki Tomioka; Toshiaki Shimizu; Tatsuo Gonda; Fusao Ota; Chiaki Sano
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

6.  Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation.

Authors:  Charles R Wira; Marcie A Roche; Richard M Rossoll
Journal:  Endocrinology       Date:  2002-08       Impact factor: 4.736

7.  Characterization and antigen-presenting function of a murine thyroid-derived epithelial cell line.

Authors:  M E Stein; M J Stadecker
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

8.  Glucocorticoid-induced growth arrest of lung alveolar epithelial cells is associated with increased production of insulin-like growth factor binding protein-2.

Authors:  O B Mouhieddine; V Cazals; E Kuto; Y Le Bouc; A Clement
Journal:  Endocrinology       Date:  1996-01       Impact factor: 4.736

9.  Mycobacterium tuberculosis invades and replicates within type II alveolar cells.

Authors:  L E Bermudez; J Goodman
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Kinetics of changes in lymphocyte sub-populations in mouse lungs after intrapulmonary infection with M. bovis (Bacillus Calmette-Guerin) and identity of cells responsible for IFNgamma responses.

Authors:  R K Saxena; D Weissman; Q B Saxena; J Simpson; D M Lewis
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

View more
  8 in total

1.  Different antigen presentation tendencies of granulocyte-macrophage colony-stimulating factor-induced bone marrow-derived macrophages and peritoneal macrophages.

Authors:  Maozhi Hu; Zhiming Pan; Yun Yang; Chuang Meng; Shizhong Geng; Meng You; Xinan Jiao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-07-18       Impact factor: 2.416

2.  The role of lipid raft aggregation in the infection of type II pneumocytes by Mycobacterium tuberculosis.

Authors:  Kari Fine-Coulson; Barbara J Reaves; Russell K Karls; Frederick D Quinn
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

3.  Loss of proliferation and antigen presentation activity following internalization of polydispersed carbon nanotubes by primary lung epithelial cells.

Authors:  Mandavi Kumari; Sumedha Sachar; Rajiv K Saxena
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

4.  Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.

Authors:  Xiaochun Wang; Jingyan Zhang; Jinping Liang; Ying Zhang; Xindong Teng; Xuefeng Yuan; Xionglin Fan
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

5.  Evaluation of trained immunity by β-1, 3 (d)-glucan on murine monocytes in vitro and duration of response in vivo.

Authors:  Pablo Garcia-Valtanen; Ruth Marian Guzman-Genuino; David L Williams; John D Hayball; Kerrilyn R Diener
Journal:  Immunol Cell Biol       Date:  2017-02-23       Impact factor: 5.126

6.  Microphysiologic Human Tissue Constructs Reproduce Autologous Age-Specific BCG and HBV Primary Immunization in vitro.

Authors:  Guzman Sanchez-Schmitz; Chad R Stevens; Ian A Bettencourt; Peter J Flynn; Klaus Schmitz-Abe; Gil Metser; David Hamm; Kristoffer J Jensen; Christine Benn; Ofer Levy
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

7.  Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone.

Authors:  Aneesh Thakur; Fernanda Endringer Pinto; Harald Severin Hansen; Peter Andersen; Dennis Christensen; Christian Janfelt; Camilla Foged
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

8.  Evidence of CD1d pathway of lipid antigen presentation in mouse primary lung epithelial cells and its up-regulation upon Mycobacterium bovis BCG infection.

Authors:  Zaigham Abbas Rizvi; Niti Puri; Rajiv K Saxena
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.